Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

| April 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD
Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina.

Innov Clin Neurosci. 2017;14(3–4):38–40

Tags: , , , , , , ,

Category: Commentary, Devices, Evaluations, Multiple Sclerosis, Neurology, Past Articles, Technology

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.